Not all lung cancer patients who could benefit from crizotinib are identified …

Not all lung cancer patients who could benefit from crizotinib are identified …
Almost specifically a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were most likely never smokers. Informed doctors use the test known as a FISH assay to check for the EML4-ALK fusion gene, and then if the test is …
Read far more on Healthcare Xpress

CyberKnife Cancer Institute of Chicago Gives CyberKnife Robotic …
The substantial ten,000 sq. ft. high-tech facility gives therapy to those impacted with cancers of the pancreas, brain, spine, kidney, prostate, liver and lung. The technology can also be utilized for treating certain nervous program conditions like …
Read a lot more on AZoRobotics

Varian Healthcare Systems to Support an NCI-Sponsored Phase III Study …
15, 2012 /PRNewswire/ — Varian Medical Systems (NYSE: VAR) right now announced that it has turn into a supporter of a phase III study comparing radiosurgery with surgical resection for the remedy of early-stage, high-danger, operable non-small cell lung …
Read far more on Businessweek